These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30093458)

  • 1. Phosphate Binder, Ferric Citrate, Attenuates Anemia, Renal Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in 5/6 Nephrectomized CKD Rats.
    Jing W; Nunes ACF; Farzaneh T; Khazaeli M; Lau WL; Vaziri ND
    J Pharmacol Exp Ther; 2018 Oct; 367(1):129-137. PubMed ID: 30093458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Route of intestinal absorption and tissue distribution of iron contained in the novel phosphate binder ferric citrate.
    Vaziri ND; Nunes ACF; Said H; Khazaeli M; Liu H; Zhao Y; Jing W; Cogburn K; Alikhani L; Lau WL
    Nephrol Dial Transplant; 2020 Jul; 35(7):1136-1144. PubMed ID: 32514572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferric Citrate Attenuates Cardiac Hypertrophy and Fibrosis in a Rat Model of Chronic Kidney Disease.
    Goto M; Suematsu Y; Nunes ACF; Jing W; Khazaeli M; Lau WL; Vaziri ND
    Iran J Kidney Dis; 2019 Mar; 13(2):98-104. PubMed ID: 30988246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.
    Lau WL; Liu SM; Pahlevan S; Yuan J; Khazaeli M; Ni Z; Chan JY; Vaziri ND
    Dig Dis Sci; 2015 May; 60(5):1215-22. PubMed ID: 25399330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation.
    Vaziri ND; Yuan J; Rahimi A; Ni Z; Said H; Subramanian VS
    Nephrol Dial Transplant; 2012 Jul; 27(7):2686-93. PubMed ID: 22131233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
    Francis C; Courbon G; Gerber C; Neuburg S; Wang X; Dussold C; Capella M; Qi L; Isakova T; Mehta R; Martin A; Wolf M; David V
    Kidney Int; 2019 Dec; 96(6):1346-1358. PubMed ID: 31668632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Phosphate Binder Ferric Citrate Alters the Gut Microbiome in Rats with Chronic Kidney Disease.
    Lau WL; Vaziri ND; Nunes ACF; Comeau AM; Langille MGI; England W; Khazaeli M; Suematsu Y; Phan J; Whiteson K
    J Pharmacol Exp Ther; 2018 Dec; 367(3):452-460. PubMed ID: 30287477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited.
    Nakanishi T; Hasuike Y; Nanami M; Yahiro M; Kuragano T
    Nephrol Dial Transplant; 2016 Oct; 31(10):1588-94. PubMed ID: 26142396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tangeretin ameliorates renal failure via regulating oxidative stress, NF-κB-TNF-α/iNOS signalling and improves memory and cognitive deficits in 5/6 nephrectomized rats.
    Wu J; Zhao YM; Deng ZK
    Inflammopharmacology; 2018 Feb; 26(1):119-132. PubMed ID: 28871498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease.
    Aminzadeh MA; Reisman SA; Vaziri ND; Shelkovnikov S; Farzaneh SH; Khazaeli M; Meyer CJ
    Redox Biol; 2013; 1(1):527-31. PubMed ID: 24363993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
    Aminzadeh MA; Reisman SA; Vaziri ND; Khazaeli M; Yuan J; Meyer CJ
    Xenobiotica; 2014 Jun; 44(6):570-8. PubMed ID: 24195589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
    Toblli JE; Cao G; Rivas C; Giani JF; Dominici FP
    Int J Cardiol; 2016 Jun; 212():84-91. PubMed ID: 27038710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.
    Vaziri ND; Liu S; Farzaneh SH; Nazertehrani S; Khazaeli M; Zhao YY
    Free Radic Biol Med; 2015 Sep; 86():374-81. PubMed ID: 25930007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
    Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
    Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misdistribution of iron and oxidative stress in chronic kidney disease.
    Nakanishi T; Kuragano T; Nanami M; Nagasawa Y; Hasuike Y
    Free Radic Biol Med; 2019 Mar; 133():248-253. PubMed ID: 29958932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption.
    Vaziri ND; Yuan J; Khazaeli M; Masuda Y; Ichii H; Liu S
    Am J Nephrol; 2013; 37(6):518-25. PubMed ID: 23689670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction.
    Vaziri ND; Yuan J; Nazertehrani S; Ni Z; Liu S
    Am J Nephrol; 2013; 38(2):99-103. PubMed ID: 23887095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study.
    Tanaka M; Miyamura S; Imafuku T; Tominaga Y; Maeda H; Anraku M; Yamasaki K; Kadowaki D; Ishima Y; Watanabe H; Okuda T; Itoh K; Matsushita K; Fukagawa M; Otagiri M; Maruyama T
    Biol Pharm Bull; 2016; 39(6):1000-6. PubMed ID: 27251502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferric citrate for the treatment of hyperphosphatemia and anemia in patients with chronic kidney disease: a meta-analysis of randomized clinical trials.
    Li L; Zheng X; Deng J; Zhou J; Ou J; Hong T
    Ren Fail; 2022 Dec; 44(1):1112-1122. PubMed ID: 35912897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
    Biruete A; Metzger CE; Chen NX; Swallow EA; Vrabec C; Clinkenbeard EL; Stacy AJ; Srinivasan S; O'Neill K; Avin KG; Allen MR; Moe SM
    Nephrol Dial Transplant; 2022 Sep; 37(10):1857-1867. PubMed ID: 35482713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.